Lai Goldman Myla insider trades
Lai Goldman Myla has filed 15 Form 4s with the SEC that we hold, for AKYA (Director), West Pharmaceutical Services INC (WST) (Director) and Quanterix Corp (QTRX) (Director). Across all of them we count 1 purchase worth $100.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 20,000 shares of AKYA worth $100.0K, dated 2023-06-12. The first filing on our record is dated 2021-09-20 and the latest 2026-07-09.
AKYA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-12 | P, purchase reported on Form 4 | 20,000 | $100.0K | 2023-06-12 |
West Pharmaceutical Services INC (WST)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Quanterix Corp (QTRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1168581) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms